This novel study aimed to visualize the serum SARM1 levels in humans and to confirm the hypothesis that serum SARM1 may be closely related to the severity of neuropathy in patients with T2DM as well as the possible effects of COVID-19 vaccination. The gene discussed is SARM1; the disease is COVID-19.